Time-Restricted Eating and Muscle Hypertrophy

Sponsor
California State University, Fullerton (Other)
Overall Status
Suspended
CT.gov ID
NCT04000750
Collaborator
San Francisco State University (Other)
40
1
2
29.3
1.4

Study Details

Study Description

Brief Summary

The purpose is to examine the effects of time-restricted eating (TRE; consuming all calories within an 8-hour period each day) vs. normal eating (CON; consuming same kcals and protein as TRE, but during a 10-13 hr eating window each day) during 8 weeks of resistance exercise on body composition and muscle mass (whole muscle and single fiber), muscular performance, anabolic protein signaling, single muscle fiber characteristics, and the gut microbiome in well-trained young men and women.

Condition or Disease Intervention/Treatment Phase
  • Other: Time Restricted Eating
  • Other: Normal Feeding
  • Other: Resistance Training
  • Dietary Supplement: Whey Protein
N/A

Detailed Description

The primary goal pertains to muscle hypertrophy (not fat loss), thus all participants will be placed in a 10% caloric surplus.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
40 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Investigator, Outcomes Assessor)
Masking Description:
Participants will know their group. Training and Nutrition research team members will know the participants group. Data analysis team will be blinded to condition.
Primary Purpose:
Other
Official Title:
The Influence of 16:8 Time-Restricted Eating on Resistance Exercise-Induced Skeletal Muscle Hypertrophy
Actual Study Start Date :
Jun 24, 2019
Anticipated Primary Completion Date :
Jul 1, 2021
Anticipated Study Completion Date :
Dec 1, 2021

Arms and Interventions

Arm Intervention/Treatment
Experimental: Time Restricted Eating (16:8)

Participants will consume all calories within an 8 hour window each day.

Other: Time Restricted Eating
Diet will be tracked and reported every day to a qualified dietitian.

Other: Resistance Training
8 weeks of supervised and programmed whole body resistance training, performed 4x per week

Dietary Supplement: Whey Protein
Consumed on all exercise days.

Active Comparator: Control

Participants will consume all calories within a ~12 hour window each day (4 separate meals + needed snacks).

Other: Normal Feeding
Diet will be tracked and reported every day to a qualified dietitian.

Other: Resistance Training
8 weeks of supervised and programmed whole body resistance training, performed 4x per week

Dietary Supplement: Whey Protein
Consumed on all exercise days.

Outcome Measures

Primary Outcome Measures

  1. Changes in Muscle Size - Lower Body [Pre, Mid (4 weeks), and Post (8 weeks)]

    via Ultrasound

  2. Changes in Muscle Size - Upper Body [Pre, Mid (4 weeks), and Post (8 weeks)]

    via Ultrasound

  3. Changes in Fiber Type-Specific Size [Pre and Post (week 8)]

    Single muscle fiber analysis

  4. Changes in Body composition [Pre, Mid (4 weeks), and Post (8 weeks)]

    via BodPod

  5. Acute Exercise Induced Fiber Type-Specific Anabolic Signaling (Total Concentration and Phosphorylation Status) [Day 1 of exercise training]

    Men only; assessed via single fiber Simple Western

Secondary Outcome Measures

  1. Changes in Maximal Strength [Pre and Post (week 8)]

    1RM on bench press, squat, and leg extension

  2. Changes in Maximal Muscular Endurance [Pre and Post (week 8)]

    Maximal repetitions on bench press and leg press

  3. Changes in Gut Microbiome [Pre, Mid (week 2, 4, 6), and Post (week 8)]

    via stool sample

  4. Changes in Fiber Type Composition [Pre and Post (week 8)]

    Single Fiber via SDS-PAGE

  5. Changes in Fiber Type-Specific Resting Anabolic Signaling (Total Concentration and Phosphorylation Status) [Pre and Post (week 8)]

    via single fiber Simple Western

  6. Changes in Mood [Weekly for duration of the intervention (8 weeks)]

    via Questionnaire

  7. Changes in Enjoyment of Diet [Weekly for duration of the intervention (8 weeks)]

    via Questionnaire

  8. Changes in Sleep (total and quality) [Weekly for duration of the intervention (8 weeks)]

    via Questionnaire

  9. Changes in Menstrual Cycle [Pre, Mid (week 4), and post (week 8)]

    via Questionnaire; women only

  10. Total Training Volume [After 8 weeks]

  11. Nutrient Intake [Daily, starting 7 days before the study and continuing for 8 additional weeks]

    Total Kcal and grams of protein, fat, and carbohydrates

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 35 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • 18-35 years old with <25% (men) or <30% (women) body fat

  • have experience in resistance exercise for the whole body and performed resistance exercise at least 3 times per week the last 12 months

  • be able to perform all necessary exercises with safe technique and no pain

  • be able to squat 1.5x (men) or 1x (women) body weight

  • be able to bench press 1.1x (men) or 0.55x (women) body weight

  • be on a non-specialized, mixed macronutrient diet

  • have a lifestyle which enables a reasonably consistent 7+ hours of sleep per night

  • be free of any current joint, musculoskeletal, and/or neuromuscular injuries

Exclusion Criteria:
  • have any known current illness, prohibitive muscular or neuromuscular problem, hypertension, cardiac, pulmonary, liver, kidney, insulin or any other metabolic disorders (e.g. Type I or Type II diabetes)

  • are lactose intolerant or unable to consume whey protein for any reason

  • are on any medications known to affect protein metabolism

  • have taken antibiotics in the last 6 months

  • cannot refrain from consuming any alcoholic beverages, nicotine, or marijuana (or derivative) for a period of 48 hours prior to data collection (pre and post testing)

  • consume alcohol >2x per week

  • consume any analgesic or anti-inflammatory drug(s), prescription or non-prescription, chronically or within 48 hours of data collection

  • consume any recreational drug(s), prescription or non-prescription, legal or illegal, chronically or within 30 days of data collection

  • consume any caffeine or food within 12 hours of data collection

  • cannot refrain from physical exercise (outside of activities of daily living) outside of what is prescribed by the research team for the duration of the study

  • cannot refrain from using recovery methods such as electric stimulation, hot/cold therapy, massage, chiropractic, or personal air/water devices (Normatech, etc.)

  • have utilized any anabolic steroid, currently or in the past

  • cannot refrain from consumption of any supplementation (creatine, multivitamin, fish oil, protein powder, BCAA, pre-workouts, etc.) outside of what is provided

  • cannot refrain from consuming any supplemental pro or prebiotics or other items that intentionally alter the gut microbiome

  • fail to adhere to the nutritional guidelines or miss >3 of the exercise sessions

  • were recently pregnant, trying to become pregnant, or are currently breastfeeding

Contacts and Locations

Locations

Site City State Country Postal Code
1 Center for Sport Performance at California State University, Fullerton Fullerton California United States 92831

Sponsors and Collaborators

  • California State University, Fullerton
  • San Francisco State University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Andrew Galpin, Associate Professor, California State University, Fullerton
ClinicalTrials.gov Identifier:
NCT04000750
Other Study ID Numbers:
  • CSP Fullerton
First Posted:
Jun 27, 2019
Last Update Posted:
Jan 27, 2021
Last Verified:
Jan 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Andrew Galpin, Associate Professor, California State University, Fullerton
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jan 27, 2021